$1.65 Billion is the total value of CLIFFORD SWAN INVESTMENT COUNSEL LLC's 297 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EEP | Exit | Enbridge Energy Partners LP | $0 | – | -12,100 | -100.0% | -0.01% | – |
PSLV | Exit | Sprott Physical Silver Trust Eaa | $0 | – | -30,000 | -100.0% | -0.01% | – |
BMS | Exit | Bemis Company | $0 | – | -4,140 | -100.0% | -0.01% | – |
ILMN | Exit | Illumina, Inc. | $0 | – | -545 | -100.0% | -0.01% | – |
TYG | Exit | Tortoise Energy Infretf | $0 | – | -8,130 | -100.0% | -0.01% | – |
IYC | Exit | iShares Goldman Sachs Cons Svcetf | $0 | – | -1,000 | -100.0% | -0.01% | – |
VIG | Exit | Vanguard Dividend Apprec Fdetf | $0 | – | -1,858 | -100.0% | -0.01% | – |
LLL | Exit | L3 TECHNOLOGIES INC COM | $0 | – | -1,001 | -100.0% | -0.01% | – |
IWD | Exit | iShares Tr Russell 1000 Valueetf | $0 | – | -1,685 | -100.0% | -0.01% | – |
TMK | Exit | Torchmark Corp | $0 | – | -2,540 | -100.0% | -0.01% | – |
GSK | Exit | GlaxoSmithKline PLC-ADR | $0 | – | -5,160 | -100.0% | -0.01% | – |
AGG | Exit | iShares Core U.S. Aggregate Boetf | $0 | – | -1,926 | -100.0% | -0.01% | – |
IWF | Exit | iShares Russell 1000 Growthetf | $0 | – | -1,356 | -100.0% | -0.01% | – |
BLK | Exit | Blackrock 2001 | $0 | – | -495 | -100.0% | -0.01% | – |
RSP | Exit | PowerShares S&P 500 Equal Wt Petf | $0 | – | -2,180 | -100.0% | -0.01% | – |
ABC | Exit | AmerisourceBergen Corporation | $0 | – | -2,441 | -100.0% | -0.01% | – |
IYH | Exit | iShares Goldman Sachs Health Cetf | $0 | – | -1,100 | -100.0% | -0.01% | – |
SLY | Exit | SPDR S&P 600 Small Cap ETFetf | $0 | – | -3,000 | -100.0% | -0.01% | – |
FDX | Exit | FedEx Corporation | $0 | – | -950 | -100.0% | -0.01% | – |
VONE | Exit | Vanguard Russell 1000etf | $0 | – | -2,064 | -100.0% | -0.01% | – |
APC | Exit | Anadarko Petroleum Corp | $0 | – | -3,996 | -100.0% | -0.01% | – |
RCL | Exit | Royal Caribbean Cruise | $0 | – | -2,000 | -100.0% | -0.01% | – |
SCHB | Exit | Schwab U.S. Broad Market ETFetf | $0 | – | -4,142 | -100.0% | -0.02% | – |
ADNT | Exit | Adient PLC | $0 | – | -8,882 | -100.0% | -0.02% | – |
ETP | Exit | Energy Transfer Partners, LP. | $0 | – | -15,796 | -100.0% | -0.02% | – |
ARNA | Exit | Arena Pharmaceuticals | $0 | – | -8,915 | -100.0% | -0.02% | – |
COL | Exit | Rockwell Collins | $0 | – | -2,944 | -100.0% | -0.02% | – |
HAIN | Exit | Hain Celestial Group Inc. | $0 | – | -16,045 | -100.0% | -0.02% | – |
ESRX | Exit | Express Scripts Holding Compan | $0 | – | -6,264 | -100.0% | -0.03% | – |
SCHM | Exit | Schwab U.S. Mid-Cap ETFetf | $0 | – | -10,794 | -100.0% | -0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
UNITED PARCEL SERVICE INC | 42 | Q3 2023 | 5.9% |
APPLE INC | 42 | Q3 2023 | 6.2% |
MICROSOFT CORP | 42 | Q3 2023 | 4.6% |
BERKSHIRE HATHAWAY INC DEL | 42 | Q3 2023 | 2.9% |
COSTCO WHSL CORP NEW | 42 | Q3 2023 | 3.1% |
JOHNSON & JOHNSON | 42 | Q3 2023 | 3.0% |
ExxonMobil Corporation | 42 | Q3 2023 | 4.2% |
ACCENTURE PLC IRELAND | 42 | Q3 2023 | 2.9% |
WELLS FARGO CO NEW | 42 | Q3 2023 | 2.7% |
CHEVRON CORP NEW | 42 | Q3 2023 | 2.6% |
View CLIFFORD SWAN INVESTMENT COUNSEL LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-17 |
13F-HR | 2024-02-06 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-04 |
13F-HR | 2023-05-05 |
13F-HR | 2023-02-03 |
13F-HR | 2022-11-07 |
13F-HR | 2022-08-04 |
13F-HR | 2022-05-03 |
13F-HR | 2022-02-11 |
View CLIFFORD SWAN INVESTMENT COUNSEL LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.